A new fluid biomarker for Parkinson’s disease (PD) was developed, offering a high-accuracy biological classification, ...

Parkinson's disease is a neurodegenerative disorder that is usually diagnosed in its late stage on the basis of clinical ...

Researchers have identified a key enzyme driving forms of Parkinson's disease, and have shown how blocking it restores normal ...

The relationship between pathology in the brain and alterations in the gut microbiome could lead to therapies — even if it’s ...

Parkinson's disease (PD) and Lewy body dementia (LBD ... Both diseases involve Lewy bodies—abnormal clumps of α-synuclein protein in brain cells. Previous research on Lewy bodies has often focused on ...

Parkinson’s disease (PD) and Lewy body dementia (LBD ... Both diseases involve Lewy bodies—abnormal clumps of α-synuclein protein in brain cells. Previous research on Lewy bodies have often focused on ...

Parkinson’s disease (PD ... Both involve Lewy bodies—clumps of α-synuclein protein in brain cells. While past studies focused on the rigid fibril core, new research by HE Zhuohao's team ...

See α-Synuclein. Candidate tracer SY08 detects α-synuclein deposits in the brainstem (right) and parietal cortex (left) of ...

Parkinson's disease is linked to gut microbiome imbalances, impacting alpha-synuclein accumulation and triggering inflammation. Gastrointestinal issues like constipation and nausea are common ...

Researchers have identified a key enzyme driving forms of Parkinson’s, and have shown how blocking it restores normal ...